ctrl K

Watchlist Price Alert

Radiopharm Theranostics L... (RADX)

NASDAQ: RADX · Real-Time Price · USD

5.08

-0.04 (-0.84%)

At close: Jun 17, 2025, 3:39 PM

5.27

3.64%

After-hours: Jun 17, 2025, 07:58 PM EDT

Radiopharm Theranostics Income Statement

Financials in AUD. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Revenue	299.23K	292.36K	8.83K
Cost of Revenue	n/a	n/a	n/a
Gross Profit	299.23K	292.36K	8.83K
Operating Income	-36.62M	-34.51M	-19.92M
Interest Income	50.48K	145.03K	n/a
Pretax Income	-47.85M	-34.57M	-30.29M
Net Income	-47.95M	-34.61M	-30.34M
Selling & General & Admin	15.22M	13.02M	10.85M
Research & Development	17.56M	13.8M	4.12M
Other Expenses	4.14M	7.98M	4.95M
Operating Expenses	36.92M	34.8M	19.93M
Interest Expense	642.89K	86.09K	9.35M
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	36.92M	34.8M	19.93M
Income Tax Expense	96.36K	38.01K	44.4K
Shares Outstanding (Basic)	1.29M	1.02M	n/a
Shares Outstanding (Diluted)	1.29M	1.02M	n/a
EPS (Basic)	n/a	n/a	n/a
EPS (Diluted)	n/a	n/a	n/a
EBITDA	-44.08M	-31.19M	-17.96M
EBIT	-47.21M	-34.49M	-20.94M
Depreciation & Amortization	3.13M	3.3M	2.98M